Barabasz W, Albińska D, Jaśkowska M, Lipiec J (2002) Ecotoxicology of aluminium. Pol J Environ Stud 11:199–203. https://doi.org/10.1023/a:1013741012993
Alabi OA, Adeoluwa YM (2020) Production, usage, and potential public health effects of aluminum cookware: A review. Ann Sci Technol 5:29–36. https://doi.org/10.2478/ast-2020-0003
Boopathi S, Mendonca E, Gandhi A et al (2024) Exploring the combined effect of exercise and apigenin on aluminium-induced neurotoxicity in zebrafish. Mol Neurobiol 61:1874–1888. https://doi.org/10.1007/s12035-024-03913-2
Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF (2009) Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol 169:489–496. https://doi.org/10.1093/aje/kwn348
Maya S, Prakash T, Madhu KD, Goli D (2016) Multifaceted effects of aluminum in neurodegenerative diseases: a review. Biomed Pharmacother 83:746–754. https://doi.org/10.1016/j.biopha.2016.07.035
Article CAS PubMed Google Scholar
Closset M, Cailliau K, Slaby S, Marin M (2022) Effects of aluminium contamination on the nervous system of freshwater aquatic vertebrates: a review. Int J Mol Sci 23:31–46. https://doi.org/10.3390/ijms23010031
Raduan SZ, Ahmed QU, Rusmili MRA (2025) Neurotoxicity of aluminium chloride and okadaic acid in zebrafish: unravelling Alzheimer’s disease model via learning and memory function evaluation. Neurol Perspect 4:100180. https://doi.org/10.1016/j.neurop.2024.100180
Mold M, Linhart C, Gómez-Ramírez J, Villegas-Lanau A, Exley C (2020) Aluminum and amyloid-β in familial alzheimer’s disease. J Alzheimers Dis 73:889–903. https://doi.org/10.3233/jad-191140
Zhu X, Hao W, Liu Z et al (2023) Aluminum induces neuroinflammation via P2X7 receptor activating NLRP3 inflammasome pathway. Ecotoxicol Environ Saf 250:114373. https://doi.org/10.1016/j.ecoenv.2022.114373
Abdul Manap AS, Almadodi R, Sultana S et al (2024) Alzheimer’s disease: a review on the current trends of the effective diagnosis and therapeutics. Front Aging Neurosci 16:1429211. https://doi.org/10.3389/fnagi.2024.1429211
Article CAS PubMed PubMed Central Google Scholar
Perez Ortiz JM, Swerdlow RH, Russell Swerdlow CH (2019) Mitochondrial dysfunction in Alzheimer’s disease: role in pathogenesis and novel therapeutic opportunities. Br J Pharmacol 176:3489–3507. https://doi.org/10.1111/bph.14585
Article CAS PubMed PubMed Central Google Scholar
Hampel H, Mesulam MM, Cuello AC et al (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain 141:1917–1933. https://doi.org/10.1093/brain/awy132
Article PubMed PubMed Central Google Scholar
Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer’s disease: current evidence and future directions. Alzheimers Dement 12:719–732. https://doi.org/10.1016/j.jalz.2016.02.010
Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F (2021) Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology 190:108352. https://doi.org/10.1016/j.neuropharm.2020.108352
Article CAS PubMed Google Scholar
Carvajal FJ, Inestrosa NC (2011) Interactions of AChE with Aβ aggregates in Alzheimer’s brain: therapeutic relevance of IDN 5706. Front Mol Neurosci 4:19. https://doi.org/10.3389/fnmol.2011.00019
Article CAS PubMed PubMed Central Google Scholar
Tamagno E, Guglielmotto M, Vasciaveo V, Tabaton M (2021) Oxidative stress and beta amyloid in Alzheimer’s disease: which comes first, the chicken or the egg? Antioxidants 10:1479. https://doi.org/10.3390/antiox10091479
Article CAS PubMed PubMed Central Google Scholar
Kimura AM, Tsuji M, Yasumoto T et al (2021) Myricetin prevents high molecular weight Aβ1–42 oligomer-induced neurotoxicity through antioxidant effects in cell membranes and mitochondria. Free Radic Biol Med 168:522–530. https://doi.org/10.1016/j.freeradbiomed.2021.05.019
Meng M, Zhang L, Ai D, Wu H, Peng W (2021) β-Asarone ameliorates β-amyloid–induced neurotoxicity in PC12 cells by activating PI3K/Akt/Nrf2 signaling pathway. Front Pharmacol 12:659955. https://doi.org/10.3389/fphar.2021.659955
Article CAS PubMed PubMed Central Google Scholar
Padurariu M, Ciobica A, Lefter R, Lacramioara Serban I, Stefanescu C, Chirita R (2013) The oxidative stress hypothesis in Alzheimer’s disease. Psychiatr Danub 25:401–409. https://doi.org/10.2298/abs1302507s
Article CAS PubMed Google Scholar
Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40. https://doi.org/10.1016/j.cbi.2005.12.009
Article CAS PubMed Google Scholar
Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M (2024) Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch Toxicol 98:1431–1478. https://doi.org/10.1007/s00204-024-03696-4
Petrovic S, Arsic A, Ristic-Medic D, Cvetkovic Z, Vucic V (2020) Lipid peroxidation and antioxidant supplementation in neurodegenerative diseases: a review of human studies. Antioxidants 9:1128. https://doi.org/10.3390/antiox9111128
Article CAS PubMed PubMed Central Google Scholar
Ashour NH, El-Tanbouly DM, El Sayed NS, Khattab MM (2021) Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: involvement of nitric oxide status, Aβ extrusion transporter ABCB1, and reversal by PKA inhibitor H89. Prog Neuropsychopharmacol Biol Psychiatry 111:110366. https://doi.org/10.1016/j.pnpbp.2021.110366
Article CAS PubMed Google Scholar
Xu JJ, Guo S, Xue R, Xiao L, Kou JN, Liu YQ, Han JY, Fu JJ, Wei N (2021) Adalimumab ameliorates memory impairments and neuroinflammation in chronic cerebral hypoperfusion rats. Aging 13:22134–22152. https://doi.org/10.18632/aging.203009
Article PubMed PubMed Central Google Scholar
Lyra e Silva NM, Gonçalves RA, Pascoal TA et al (2021) Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in alzheimer’s disease. Transl Psychiatry 11:251. https://doi.org/10.1038/s41398-021-01349-
Article CAS PubMed PubMed Central Google Scholar
Blevins HM, Xu Y, Biby S, Zhang S (2022) The NLRP3 inflammasome pathway: mechanisms and inhibitors for the treatment of inflammatory diseases. Front Aging Neurosci 14:879021. https://doi.org/10.3389/fnagi.2022.879021
Article CAS PubMed PubMed Central Google Scholar
Spead O, Verreet T, Donelson CJ, Poulain FE (2018) Characterization of the caspase family in zebrafish. PLoS One 13(5):e0197966. https://doi.org/10.1371/journal.pone.0197966
Article CAS PubMed PubMed Central Google Scholar
Waiker DK, Karthikeyan C, Poongavanam V et al (2014) Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors. Bioorg Med Chem 22:3553–3565. https://doi.org/10.1016/j.bmc.2014.01.044
Kashif M, Chandrabose K, Pandurangan AK (2024) Plausible action of N-(3,4-dimethoxy-phenyl)-6,7-dimethoxyquinazoline-4-amine (TKM01) as an armor against Alzheimer’s disease: in silico and in vivo insights. J Biochem Mol Toxicol 38:e70048. https://doi.org/10.1002/jbt.70048
Comments (0)